Ridhima Biocare
Dicyclomine (10mg) + Simethicone (40mg)
Defispas Oral Drops is a medication used to treat stomach pain, bloating, and abdominal cramps, as well as symptoms of irritable bowel syndrome.
Oral Drops
Defispas Oral Drops is commonly given to treat stomach pain, bloating, and abdominal cramps, and pain associated with excessive acidity, gas, infections, and gastrointestinal tract diseases. It also controls symptoms of irritable bowel syndrome. It relaxes the muscles of the gut and absorbs the extra gas.
Inform your doctor if you experience severe or long-lasting pain in your stomach.
Defispas Oral Drops is a mixture of two active medicines Dicyclomine, an antispasmodic agent, and Simethicone, an antifoaming medicine. Dicyclomine works by relaxing the muscles in your stomach and gut (intestine). It stops sudden muscle contractions (spasms) thereby relieving abdominal cramps and pain. Whereas Simethicone disintegrates gas bubbles and allows easy passage of gas.
Inform your doctor if you experience severe or long-lasting pain in your stomach. Give your child a diet that is rich in fiber and low in fermentable sugars. Avoid giving gas-producing foods to your child such as beans, onions, carrots, raisins, and bananas. Encourage your child to exercise daily as it has potential benefits in constipation and in improving overall wellbeing. In children less than 2 months of age, do not give Defispas Oral Drops without ruling out the reasons that might be making your child cry. Give Defispas Oral Drops only if your child shows actual signs of abdominal discomfort or pain after consulting your child’s doctor.
Abdominal pain accompanied by nausea, vomiting, and photophobia could potentially be a symptom of abdominal migraine, characterized by recurrent episodes of dull or moderate to severe abdominal pain lasting at least six months. Abdominal pain often coexists with additional features such as anorexia, nausea, vomiting, headache, photophobia, and pallor. It is important to rule out potential causes like this before administering Defispas Oral Drops.
In routine examinations, the doctor may recommend an abdominal ultrasound. In more serious cases, endoscopy and esophageal pH monitoring may be considered.
Defispas Oral Drops should not be used in situations with obstructive or inflammatory digestive tract diseases such as heartburn, unstable cardiovascular disease, obstructive uropathy, glaucoma, muscle weakness disorder, liver impairment, hyperthyroidism, neuropathy, and kidney impairment.
Defispas Oral Drops may interact with other medicines or substances. It is crucial to inform your doctor about any other medication your child is taking before starting Defispas Oral Drops. Consult your child’s healthcare provider for guidance on administering any new medications.
Defispas Oral Drops should be stored at room temperature, away from direct sunlight and heat sources. Always keep the medication out of reach and sight of children to prevent accidental ingestion.